Compare
Intuitive Surgical vs West Pharmaceutical Services
MonkScore ranges and fundamentals, side by side
Key facts
Intuitive Surgical and West Pharmaceutical Services: key facts
- In fiscal 2025, Intuitive Surgical, Inc. reported revenue of $10.1B and net income of $2.9B.
- In fiscal 2025, West Pharmaceutical Services, Inc. reported revenue of $3.1B and net income of $493.7M.
- Intuitive Surgical, Inc.'s revenue grew 15.2% a year from fiscal 2021 to fiscal 2025.
- West Pharmaceutical Services, Inc.'s revenue grew 2.1% a year from fiscal 2021 to fiscal 2025.
- Intuitive Surgical, Inc.'s free cash flow was positive in 5 of the 5 fiscal years from 2021 to 2025.
- West Pharmaceutical Services, Inc.'s free cash flow was positive in 5 of the 5 fiscal years from 2021 to 2025.
- In the twelve months to 30 September 2026, Intuitive Surgical, Inc. reported revenue of $11.6B and net income of $3.0B.
- In the twelve months to 30 September 2026, West Pharmaceutical Services, Inc. reported revenue of $3.4B and net income of $638.9M.
Side by side
Intuitive Surgical and West Pharmaceutical Services, side by side
Each figure is in the company's reporting currency, with its fiscal year or the date of its last report.
| Figure | Intuitive Surgical, Inc.NASDAQ:ISRG | West Pharmaceutical Services, Inc.NYSE:WST |
|---|---|---|
| MonkScore | ||
| MonkScore range | 90–100as of October 2026 | 90–100as of October 2026 |
| Sector rank | 23 of 628 in Healthcare | 35 of 628 in Healthcare |
| How this score is madeDisclaimer | ||
| Profile | ||
| Sector | Healthcare | Healthcare |
| Industry | Medical - Instruments & Supplies | Medical - Instruments & Supplies |
| Latest fiscal year | ||
| Revenue | $10.1BFY 2025 | $3.1BFY 2025 |
| Net income | $2.9BFY 2025 | $493.7MFY 2025 |
| Free cash flow | $2.5BFY 2025 | $468.9MFY 2025 |
| Operating cash flow | $3.0BFY 2025 | $754.8MFY 2025 |
| Total debt | $302.8MFY 2025 | $416.7MFY 2025 |
| Cash | $3.4BFY 2025 | $791.3MFY 2025 |
| Last 12 months | ||
| Revenue | $11.6Bto 30 September 2026 | $3.4Bto 30 September 2026 |
| Net income | $3.0Bto 30 September 2026 | $638.9Mto 30 September 2026 |
| Free cash flow | $3.6Bto 30 September 2026 | $453.4Mto 30 September 2026 |
| Operating cash flow | $4.1Bto 30 September 2026 | $654.5Mto 30 September 2026 |
| Total debt | $0.0to 30 September 2026 | $305.0Mto 30 September 2026 |
| Cash | $3.0Bto 30 September 2026 | $464.1Mto 30 September 2026 |
Company pages
Each company on its own
MonkStreet provides research, not investment advice.